Lineage Cell Therapeutics Inc (LCTX)
1.12
+0.02
(+1.82%)
USD |
NYAM |
Apr 25, 11:07
Lineage Cell Therapeutics Total Assets (Quarterly): 101.02M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.02M |
| September 30, 2023 | 106.15M |
| June 30, 2023 | 111.69M |
| March 31, 2023 | 113.20M |
| December 31, 2022 | 123.66M |
| September 30, 2022 | 131.15M |
| June 30, 2022 | 135.92M |
| March 31, 2022 | 144.52M |
| December 31, 2021 | 174.54M |
| September 30, 2021 | 131.21M |
| June 30, 2021 | 134.75M |
| March 31, 2021 | 127.93M |
| December 31, 2020 | 107.95M |
| September 30, 2020 | 103.09M |
| June 30, 2020 | 112.08M |
| March 31, 2020 | 118.88M |
| December 31, 2019 | 125.48M |
| September 30, 2019 | 132.98M |
| June 30, 2019 | 151.69M |
| March 31, 2019 | 183.72M |
| December 31, 2018 | 101.66M |
| September 30, 2018 | 176.08M |
| June 30, 2018 | 112.25M |
| March 31, 2018 | 110.40M |
| December 31, 2017 | 173.24M |
| Date | Value |
|---|---|
| September 30, 2017 | 221.87M |
| June 30, 2017 | 193.35M |
| March 31, 2017 | 205.22M |
| December 31, 2016 | 142.57M |
| September 30, 2016 | 147.57M |
| June 30, 2016 | 104.33M |
| March 31, 2016 | 80.11M |
| December 31, 2015 | 94.66M |
| September 30, 2015 | 76.86M |
| June 30, 2015 | 79.61M |
| March 31, 2015 | 69.70M |
| December 31, 2014 | 74.90M |
| September 30, 2014 | 55.65M |
| June 30, 2014 | 65.99M |
| March 31, 2014 | 57.95M |
| December 31, 2013 | 57.73M |
| September 30, 2013 | 30.85M |
| June 30, 2013 | 39.89M |
| March 31, 2013 | 35.30M |
| December 31, 2012 | 29.75M |
| September 30, 2012 | 32.87M |
| June 30, 2012 | 38.38M |
| March 31, 2012 | 38.98M |
| December 31, 2011 | 45.83M |
| September 30, 2011 | 50.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
101.02M
Minimum
Dec 2023
174.54M
Maximum
Dec 2021
125.68M
Average
125.48M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Acumen Pharmaceuticals Inc | 310.12M |
| Sarepta Therapeutics Inc | 3.265B |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.00M |
| Shareholders Equity (Quarterly) | 63.42M |
| Current Ratio | 2.140 |